(Circulation. 1996;94:1239-1246.)
© 1996 American Heart Association, Inc.
Articles |
Increased Neutrophil-Platelet Adhesion in Patients With Unstable Angina
Medizinische Klinik and Frauenklinik (M.S.), Technische Universitat Munchen, Germany.
Correspondence to Dr. F.-J. Neumann, I. Medizinische Klinik der Technischen Universitat Munchen, Klinikum rechts der Isar, Ismaningerstrasse 22, 81675 Munchen, Germany.
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Background Neutrophil-platelet adhesion may occur as a consequence of platelet activation. The role of this heterotypic adhesion in ischemic disorders is poorly understood thus far.
Methods and Results Systemic venous blood samples were taken from 25 patients with stable angina pectoris and 25 patients with unstable angina pectoris. Neutrophil activation and neutrophil-platelet adhesion were evaluated by two-color flow cytometry. Patients with unstable angina showed a significant increase in neutrophil-platelet adhesion compared with patients with stable angina (mean±SEM, 132.1±20.5 versus 29.8±4.7 anti-glycoprotein IIb/IIIa mean fluorescence intensity, P=.0001). Systemic neutrophil activation was found in patients with unstable angina compared with those with stable angina assessed by cell surface CD11b expression and shedding of L-selectin (115.6±10.3 versus 74.0±6.3 anti-CD11b mean fluorescence intensity, P=.002; 49.8±6.0 versus 72.1±4.0 anti–L-selectin mean fluorescence intensity, P=.006). Markers of neutrophil activation were related to the extent of neutrophil-platelet adhesion (CD11b: r=.5, P=.0005; L-selectin: r=.42, P=.012). In vitro studies revealed that binding of purified platelet membranes to control neutrophils caused a dose-dependent increase in CD11b surface expression, a decrease in surface L-selectin, and the release of superoxide anions.
Conclusions Thus, this study demonstrates that increased neutrophil-platelet adhesion may contribute to neutrophil activation in unstable angina.
Key Words: angina • leukocytes • platelets
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Acute coronary syndromes are frequently associated with a systemic inflammatory response syndrome (SIRS). The relevance of the SIRS in this setting is highlighted by a recent study1 of unstable angina showing that patients with unstable angina are at increased risk to develop major cardiac events if the serum concentration of C-reactive protein is elevated. In addition, plasma fibrinogen, another protein that is increased in SIRS, is a major cardiovascular risk factor, and elevated systemic white blood cell counts are strong predictors of the risk of myocardial infarction and its recurrence.2
The interactions of vascular cells play an important role in the development of inflammation and mediate most inflammatory effects. Among these cellular interactions, those between leukocytes and endothelial cells have been studied extensively under conditions of ischemia and reperfusion.3 4 In contrast, leukocyte-platelet interactions in ischemic disorders are still poorly understood. Neutrophil-platelet adhesion is frequently found in conditions associated with increased platelet activation.5 6 7 8 9 However, the functional relevance of this adhesion is unknown thus far.
Platelet activation plays a central role in the pathogenesis of unstable angina, and increased excretion of metabolites of platelet-release products has been found in patients with unstable angina after episodes of ischemia.10 11 12 13 We therefore investigated whether neutrophil-platelet adhesion is increased in unstable angina compared with stable angina. Moreover, to assess the functional relevance of neutrophil-platelet conjugates, we related their occurrence to the expression of activation-dependent surface receptors on neutrophils. In addition, we performed in vitro experiments to investigate whether adhesion of platelets to neutrophils induces changes in neutrophil function regardless of platelet mediator release. In these experiments, we coincubated isolated platelet membranes with neutrophils and assayed respiratory burst and activation-dependent neutrophil surface receptors.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Patient Selection
The study included 25 consecutive patients with unstable angina and 25 consecutive patients with stable angina. All patients had angiographically proven coronary artery disease. Patients with stable angina had typical angina of Canadian Cardiovascular Society functional class II. Unstable angina was defined by the presence of at least one of the following features: (1) angina of recent onset, that is, within 6 weeks, brought on by minimal exertion; (2) crescendo angina, that is, more severe, prolonged, or more frequent anginal attacks, superimposed on chronic effort angina; or (3) angina at rest lasting for
15 minutes. Exclusion criteria were: (1) interfering noncardiac disease, that is, anemia, infection, malignoma, collagen disease, diabetes mellitus, thyrotoxicosis; (2) cardiac disease other than coronary artery disease, except for minor mitral regurgitation; (3) overt right or left ventricular failure; (4) myocardial infarction, coronary artery bypass surgery, or balloon angioplasty within 3 months preceding the study; or (5) myocardial infarction evolving within 8 hours after withdrawal of blood. Baseline characteristics of the study patients are shown in Table 1
.
|
The study was approved by the institutional ethics committee for human subjects. Informed consent was obtained from all patients.
Immunofluorescence
Neutrophil staining was performed in whole-blood samples by use of dual-color immunofluorescence.14 15 Blood samples were obtained before the initiation of in-hospital therapy once the diagnosis of unstable or stable angina was established. Samples were collected in 1:10 (vol/vol) CPDA (Greiner). Staining was performed within 20 minutes of blood sampling with the use of FITC-conjugated mAbs, anti-CD11b (Bear1), anti-GP IIb/IIIa (P2), and anti–L-selectin (DREG56), as well as PE-conjugated anti-CD45 (KC56, Coulter Electronics) and negative isotype control (Immunotech). Twenty-five microliters of blood and an equal volume of Tyrode's buffer (0.1% BSA, 0.1% glucose, 2 mmol/L MgCl2, 137.5 mmol/L NaCl, 12 mmol/L NaHCO3, 2.6 mmol/L KCL, pH 7.4) were incubated with saturating concentrations of FITC- and PE-conjugated mAbs for 30 minutes at room temperature (anti-GP IIb/IIIa) or at 4°C (anti-CD11b and anti–L-selectin). Thereafter, erythrocytes were lysed and neutrophils were fixed with commercially available solutions (Immunolyse and Fixative, Coulter Electronics). After being washed three times, the cells were stored in 1% paraformaldehyde at 4°C until flow cytometric analysis was performed within 24 hours.
Platelet immunostaining was performed as previously described.16 17 18 19 Briefly, platelet-rich plasma was obtained after centrifugation at 100g for 20 minutes and incubated with saturating concentrations of the following FITC-conjugated mAbs: anti-GP IIb/IIIa, anti–P-selectin (CBL-thrombo/6, Immunotech), and anti-LIBS1 directed against LIBS on GPIIIa (kindly provided by Dr M. Ginsberg, The Scripps Research Institute, La Jolla, Calif) in a total volume of 50 µL Tyrode's buffer. After 30 minutes' incubation at room temperature in the dark, samples were fixed with 0.2% paraformaldehyde. Flow cytometric analysis of the fixed samples was performed within 24 hours after sampling.
For flow cytometry, we used a FACSscan (Becton-Dickinson) equipped with a 488-nm argon laser at 500 mW. The day-to-day reproducibility was assured by a mixture of monosized, fluorescent beads (CaliBRITE, Becton-Dickinson). The histogram generated by the PE fluorescence served to identify leukocytes as positive for anti-CD45, because this panleukocyte antigen is not present on erythroid cells or platelets. Fluorescence intensity of 10 000 leukocytes and 5000 platelets was recorded as a mean channel number over a logarithmic scale. To discriminate neutrophils from monocytes and lymphocytes, a gate was set in the forward angle and the right-angle scatter plot. Platelets were gated according to their specific light-scatter properties. More than 96% of this population was GP IIb/IIIa positive. Data were stored in list mode files and processed on a Hewlett Packard computer equipped with Consort 30 software. The mean channel of fluorescence intensity was a measure for antibody binding and thus antigen surface expression. Reference ranges for antibody binding were obtained from 25 healthy control subjects.
Neutrophil Separation
Mixed leukocyte suspensions were prepared from CPDA–anticoagulated blood samples taken from healthy volunteers. After centrifugation at 100g for 10 minutes, platelet-rich plasma was removed. Mixed leukocyte suspensions were obtained after sedimentation in the presence of 3% dextran in normal saline (wt/vol) (MW 266 000 g per mol/L) and hypotonic lysis of erythrocytes at 4°C. Cells were washed twice in Tyrode's buffer.
Purified neutrophils were obtained from the mixed leukocyte suspensions by two-step density gradient centrifugation (Histopaque 1077 and 1119, Sigma).20 21 22 The neutrophil fraction was harvested, washed twice, and resuspended in Tyrode's buffer. After this separation procedure was performed, the neutrophil content was >99% with >95% viable cells (trypan blue exclusion).
Platelet Membrane Preparation
Platelet membranes were isolated from freshly prepared platelet concentrates as previously described.16 23 After preparation of the platelet concentrate, an antiplatelet cocktail that contained prostaglandin E1 (200 µg/mL), theophylline (1 mmol/L), indomethacin (1 mmol/L), and adenosine (5 mmol/L)16 was added to prevent in vitro platelet activation. Platelets were isolated by centrifugation at 700g for 20 minutes, washed twice with Tyrode's buffer supplemented with the antiplatelet cocktail, and resuspended in 150 mmol/L NaCl, 10 mmol/L Tris buffer, pH 7.4 containing the proteinase inhibitors aprotinin (10 g/L), leupeptin (0.1 g/L), and PMSF (0.5 mmol/L). The suspension was placed in the pressure chamber of a cell disruption bomb (Parr Instruments Co), and the chamber was filled with nitrogen to achieve a pressure of 10 000 kPa. After 1 hour at room temperature, the suspension was centrifuged at 100 000g for 2 hours, and the pellet was resuspended in 150 mmol/L NaCl, 10 mmol/L Tris, pH 7.4 and layered over a 27% sucrose gradient prepared in the same buffer. After centrifugation at 30 000g for 3 hours, the platelet membranes were harvested; resuspended in 150 mmol/L NaCl, 10 mmol/L Tris, pH 7.4; homogenized with a Dounce homogenizer; and passed thorough a PD10 column (Pharmacia). The eluted fraction containing the isolated platelet membranes was collected and stored in aliquots at -70°C before use. The platelet membrane preparation used in the present study was characterized as described previously.16 SDS-PAGE and immunoblotting revealed GP IIb/IIIa as the most prominent protein along with small amounts of P-selectin and thrombospondin.16 In addition, flow cytometric analysis of membrane-coated beads suggested that the glycoprotein content of the membrane preparation resembled that of partially degranulated platelets.16 Agglutination assays of membrane-coated beads confirmed the functional integrity of the adhesion proteins.16
Inactivation of platelet membranes was performed by alkaline heat denaturation. Platelet membranes were incubated at 100°C for 20 minutes in the presence of 1 mol/L NaOH. After TCA precipitation, protein was washed with acetone to remove TCA, and additional washing steps were performed three times in PBS. Denatured platelet membranes were neutralized and resuspended in Tyrode's buffer and used in the same manner as intact membranes.
Coincubation of Neutrophils With Platelet Membranes
All coincubations were performed in Tyrode's buffer supplemented with 2 mmol/L CaCl2 and 5 mmol/L HEPES. Leukocyte suspensions or purified neutrophils were added to suspensions with various concentrations of platelet membranes or 10-7 mol/L FMLP with a final concentration of 5000 cells/µL in a total volume of 400 µL. Incubation was performed in polystyrene tubes under constant shaking at 37°C. Time-course experiments showed that neutrophil-platelet aggregation was maximal after 10 minutes' incubation (data not shown). Therefore, dose-response experiments were performed at 10 minutes. To remove nonadherent platelet membranes, cell suspensions were then washed twice and resuspended in 150 µL Tyrode's buffer. Fluorescent labeling and flow cytometry were performed as described above.
Superoxide Anion Production
Superoxide anion production by neutrophils was determined by the superoxide dismutase–inhibited reduction of cytochrome C as previously described.24 The standard reaction mixture contained 1.5x105 neutrophils, 1000 U/L dismutase (30 000 U/mg, Sigma), 45 µmol/L cytochrome C, and platelet membranes or 10-7 mol/L FMLP at a volume of 500 µL. When the basal superoxide anion production was tested, FMLP and platelet membranes were omitted from the reaction mixture. After incubation for 15 minutes at 37°C under constant shaking, we determined the dismutase-inhibited reduction of cytochrome C by measuring the absorbance at 550 nm (E550 nm=2.11x104 mol/L-1·cm-1; Twinreader, Flow Laboratories). Results are expressed as superoxide anions (in nanomoles per liter)/5x105 neutrophils/15 minutes.
Confocal Scanning Laser Microscopy
To investigate the nature of the neutrophil-platelet adhesion, images of the immunofluorescent samples from both patient groups and the control subjects were obtained with a confocal scanning laser microscope (Axiovert 35, Zeiss). In addition to the patient samples, the binding of platelet membranes to control neutrophils was investigated. Cellular structures were identified in the confocal mode and related to the bound antibody that was detected by use of fluorescence microscopy.
Other Methods
Cell counts were performed with a Sysmex Counter, model F-800 (Digitana GmbH).
No endotoxin contamination of platelet membrane preparations or of buffers was detected (E-toxate, Sigma).
Statistical Analysis
Results are expressed as mean±SEM unless otherwise indicated. Differences in frequencies between two groups were tested by 
2 test with continuity correction. Because the Kolmogorov-Smirnov test showed that the data were not normally distributed, we chose the Mann-Whitney-White U test for comparison of the two groups. Linear correlations were obtained from least-squares analysis. A value of P<.05 in the two-tailed test was regarded as significant.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Study Population
The baseline characteristics of the patients with stable and unstable angina are summarized in Table 1
. Both groups were comparable with respect to age, sex, risk factor profile, and medication (Table 1). We did not find significant differences in leukocyte or platelet counts (data not shown).
Neutrophil-Platelet Adhesion Ex Vivo
As shown in Fig 1, circulating neutrophil-platelet conjugates in patients with unstable angina were significantly increased compared with patients with stable angina (P=.0001). Fig 2 shows representative confocal and fluorescent images of neutrophils from a patient with unstable angina. Confocal scanning laser microscopy revealed that the increased anti-GP IIb/IIIa fluorescence of the neutrophils corresponded to adhering platelets.
|
|
The surface expression of CD11b was increased significantly by 36% in patients with unstable angina compared with those with stable angina (Fig 3). Concomitantly, L-selectin surface expression in unstable angina decreased by 31% compared with stable angina (P=.0062; Fig 4). In the study groups, the surface expression of CD11b and L-selectin was significantly correlated with anti-GP IIb/IIIa fluorescence on neutrophils (Fig 5).
|
|
|
In contrast to the data on neutrophils, we did not find significant differences in platelet immunofluorescence between the patient groups. Platelets from patients or healthy control subjects had similar surface GP IIb/IIIa expression. LIBS1 and P-selectin platelet surface expression were increased by trend (LIBS1, P=.07; P-selectin, P=.09) in the patients with unstable angina compared with the patients with stable angina (Table 2). In the entire group of patients with unstable angina, the surface expression of LIBS1 and P-selectin on platelets was increased by trend compared with patients with stable angina (Table 3). However, within the group of patients with unstable angina, those who presented with crescendo angina (n=14) showed a significantly higher LIBS1 and P-selectin surface expression on platelets than either patients with stable angina (P<.01) or the rest of the patients with unstable angina (LIBS1: 667±30 versus 452±50 mean fluorescence intensity, P=.003; P-selectin: 408±23 versus 337±23 mean fluorescence intensity, P=.001).
|
|
Coincubation of Leukocytes With Platelet Membranes
Neutrophils in mixed leukocyte suspensions contained low baseline levels of anti-GP IIb/IIIa fluorescence intensity, comparable to control samples obtained after whole-blood staining (Figs 1 and 6A). On the other hand, purified neutrophils showed negligible platelet binding (Fig 6A). Confocal scanning laser microscopy of neutrophils in mixed leukocyte suspensions and of purified neutrophils confirmed these flow cytometry findings.
|
and 
) or of purified neutrophils (
and ). Results are mean±SEM of six separate experiments.
In both cell preparations, fluorescent lining for GP IIb/IIIa was not observed under baseline conditions but was induced by increasing doses of purified platelet membranes (Fig 6A). Stimulation with FMLP did not alter GP IIb/IIIa fluorescence of neutrophils in mixed leukocyte suspensions or of separated neutrophils (data not shown). In the presence of purified platelet membranes, however, the GP IIb/IIIa fluorescence intensity of neutrophils increased in a dose-dependent manner. Neutrophil-platelet membrane binding was more pronounced on neutrophils in mixed leukocyte suspensions than on purified neutrophils (Fig 6A).
Increasing concentrations of platelet membranes induced an increase in CD11b surface expression on neutrophils. The extent of neutrophil surface CD11b upregulation was comparable to stimulation with 10-7 mol/L FMLP (Fig 6B).
Neutrophils in mixed leukocyte suspensions showed high levels of anti–L-selectin binding, suggesting that they had not undergone major activation. Density gradient separation, however, caused some shedding of L-selectin. Increasing concentrations of platelet membranes induced a reduction in L-selectin surface expression of neutrophils in mixed leukocyte suspensions and purified neutrophils (Fig 6C). The degree of L-selectin shedding after incubation with maximal concentrations of platelet membranes was comparable to that observed after stimulation with FMLP (Fig 6C).
In addition to the changes in surface expression of adhesion receptors on neutrophils, platelet membranes induced a dose-dependent increase in superoxide anion production of purified neutrophils. This effect was observed at similar protein concentrations as for the effect on CD11b surface expression or L-selectin shedding (Fig 7).
|
Denaturation of platelet membranes abolished neutrophil-platelet interaction as well as neutrophil activation (Table 3).
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
In the present study, we demonstrated that neutrophil-platelet adhesion was increased in unstable angina compared with stable angina and presented experimental evidence for its functional relevance as a novel mechanism for neutrophil activation.
Findings in Patients
Neutrophils from patients with unstable angina showed a substantially higher anti-GP IIb/IIIa binding than neutrophils from patients with stable angina. Neutrophils do not expose the GP IIb/IIIa complex themselves, and they can be clearly distinguished from potentially contaminating platelet aggregates by their anti-CD45 immunofluorescence signal. The anti-GP IIb/IIIa fluorescent signal detected on neutrophils, therefore, must be attributed to adhering platelets or microparticles. Confocal fluorescence laser microscopy confirmed that platelet adhesion was the source of the increased anti-GP IIb/IIIa immunofluorescence of neutrophils of patients with unstable angina.
The increase in neutrophil-platelet adhesion in patients with unstable angina was associated with an increased neutrophil anti-CD11b and a decreased anti-L-selectin immunofluorescence compared with patients with stable angina. After chemotactic stimulation, neutrophils translocated the ß2-integrin CD11b/CD18 from cellular stores to the plasma membrane and shed L-selectin.25 26 27 The observed changes in neutrophil surface receptors in unstable angina, therefore, indicated neutrophil activation. Hence, the positive correlation between anti-GP IIb/IIIa and anti-CD11b binding and the inverse correlation between anti–L-selectin and anti-GP IIb/IIIa binding suggests that neutrophil-platelet adhesion and neutrophil activation are interrelated.
There is increasing evidence that outside-in signaling by adhesion receptors can modulate cell function.28 We therefore speculated that neutrophil-platelet adhesion might induce neutrophil activation. To test this hypothesis, we performed in vitro experiments.
In Vitro Stimulation of Neutrophils by Isolated Platelet Membranes
Coincubation experiments with neutrophils and platelets are difficult to interpret because putative changes in neutrophil function may be induced by the release of platelet mediators rather than by heterotypic adhesion. For this reason, we coincubated functionally intact isolated platelet membranes with neutrophils in mixed leukocyte suspensions and neutrophils purified by density gradient separation. Neutrophils in mixed leukocyte suspensions had similar surface properties as neutrophils stained in whole blood and showed residual platelet binding. On the other hand, purified neutrophils were essentially devoid of adhering platelets. This was achieved at the expense of altered surface properties, evidenced by the substantial shedding of L-selectin during separation.
Platelet membranes bind in a dose-dependent manner to both neutrophils in mixed leukocyte suspensions and purified neutrophils. As evidence of neutrophil activation induced by platelet membrane binding, we showed a dose-dependent increase in CD11b surface expression and shedding of L-selectin in both cell preparations. In support of this finding, we further demonstrated a dose-dependent induction of the respiratory burst reaction by platelet membrane binding on purified neutrophils. Alterations in neutrophil function were only induced by functionally intact platelet membranes, whereas denatured platelet membranes had no effect. Thus, independently of platelet mediator release, the interaction of neutrophils with platelet membranes carrying functionally intact surface receptors16 induced neutrophil activation. The receptors involved in this interaction remain to be clarified. Previous studies suggested that interactions between P-selectin and sialyl-Lewisx binding sites on neutrophils play a major role in the adhesion of activated platelets and neutrophils.29 30 31 Other potential links are fibrinogen bridges between GP IIb/IIIa and CD11b/CD1832 33 34 and thrombospondin bridges between GP IV receptors on both cell lines.35
Platelet membrane binding and the accompanying cellular responses were less pronounced in purified neutrophils than in neutrophils of mixed leukocyte suspensions. Altered neutrophil surface properties in the former preparation can largely explain this difference. Moreover, in mixed leukocyte suspensions, the interaction of platelet membranes with residual adherent platelets cannot be excluded and may present an additional mechanism for neutrophil activation. Such secondary binding of platelets or platelet membranes to platelets or platelet membranes already attached to neutrophils, however, may also play a role in vivo. Moreover, in vivo, release products from adherent platelets may augment neutrophil activation by adhesion receptors. Our experiments with functionally intact platelet membranes lend strong support to the concept that the interaction of platelet membrane receptors with neutrophils induces neutrophil activation.36 37 In demonstrating the differential modulation of Mac-1 and L-selectin by platelet membrane binding, the present study elucidates a potentially important new aspect of platelet-neutrophil interaction.
Limitations of the Study
Previous studies suggested that platelet activation is an essential prerequisite for leukocyte platelet adhesion.38 In the present study, surface expression of the activated fibrinogen receptor and of P-selectin on platelets obtained from patients with unstable angina were only elevated by trend compared with stable angina. Nevertheless, we were unable to conclusively show platelet activation in unstable angina by immunologic markers. In contrast, previous studies revealed platelet activation in unstable angina, which was closely related to episodes of myocardial ischemia.10 12 39 40 41 There are several potential reasons for this discrepancy. First, substantial platelet activation may be present only in the patients with the most advanced disease. Consistent with this concept, platelet membrane markers showed considerable scatter within the entire group of patients with unstable angina. This scatter could be related in part to the variation in the patients' clinical status. Accordingly, the subgroup with crescendo angina, an entity closely related to plaque lability, showed significant elevations in activation-dependent platelet membrane markers. This finding concurs with previous studies by other investigators.13 40 41 Second, it has been shown that platelet activation in unstable angina is intermittent and related to episodes of ischemia. We did not take serial blood samples and, hence, might have missed temporary changes in relation to intermittent cardiac ischemia. Third, investigation of platelet function by analysis of cells rather than release products is always hampered by the rapid removal of activated single platelets from the circulation. Thus, we might have underestimated platelet activation by single-platelet flow cytometry. Platelet-neutrophil conjugates, however, may be more stable than activated single platelets, which may explain the difference in reliability between the assays. Thus, evaluating neutrophil-platelet adhesion may be a better way of investigating platelet activation in unstable angina than analysis of single platelets.
In studies of platelet function, there is always concern about changes occurring during and after blood sampling. Therefore, we took care to keep the sampling conditions constant between the patients. Moreover, neutrophil-platelet adhesion is known to depend on extracellular calcium.9 38 42 Because we used citrated blood samples, we can exclude substantial ex vivo neutrophil-platelet adhesion. Furthermore, previous studies5 7 38 42 have shown that anti-GP IIb/IIIa immunofluorescence represents in vivo neutrophil-platelet adhesion.
Pathophysiological Considerations and Clinical Perspectives
The present study demonstrated a functionally relevant interaction between neutrophils and platelets in unstable angina. It thereby reveals that neutrophil-platelet adhesion contributes to the activation of inflammatory cells and presents a novel link between thrombotic processes and inflammation. The findings of the present study, therefore, may help in the explanation of SIRS in acute coronary syndromes. In the future, neutrophil-platelet adhesion may become a target for pharmacological interventions to inhibit potentially harmful pathways of intercellular activation in thrombosis and inflammation.
|
Selected Abbreviations and Acronyms |
|---|
|
|
Acknowledgments |
|---|
This study was supported by a grant from the Deutsche Forschungsgemeinschaft (Ne 540/1-1), Bonn, Bad-Godesberg, Germany. The authors are grateful to Caroline Bogner, Kathrin Gloth, Corinna Kraft, and Guido Eibl for excellent technical assistance.
Received December 27, 1995; revision received April 19, 1996; accepted April 22, 1996.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med. 1994;331:417-424.
2.
Yarnell JW, Baker IA, Sweetnam PM, Bainton D, O'Brien JR, Whitehead PJ, Elwood PC. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart diseases. Circulation. 1991;83:836-844.
3. Lucchesi BR. Leukocytes and ischemia-induced myocardial injury. Annu Rev Pharmacol Toxicol. 1986;26:201-224.[Medline] [Order article via Infotrieve]
4.
Sheridan FM, Dauber IM, McMurtry IF, Lesnefsky EJ, Horwitz LD. Role of leukocytes in coronary vascular endothelial injury due to ischemia and reperfusion. Circ Res. 1991;69:1566-1574.
5. Gawaz MP, Mujais KS, Schmidt B, Gurland HJ. Platelet-leukocyte aggregation during hemodialysis. Kidney Int. 1994;46:489-495.[Medline] [Order article via Infotrieve]
6. Gawaz M, Bogner C. Changes in platelet membrane glycoproteins and platelet-leukocyte interaction during hemodialysis. Clin Investigator. 1994,72:424-429.
7.
Rinder CS, Bonan JL, Rinder HM, Mathew J, Hines R, Smith BR. Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood. 1992;79:1201-1205.
8. Hendricks JB, Pharis P, Metha JL. Flow cytometric detection and quantification of monocyte-platelet conjugates in ischemic disease. Circulation. 1993;88(suppl I):I-153. Abstract.
9.
Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR. Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood. 1991;78:1760-1769.
10. Grande P, Grauholt AM, Madsen JK. Unstable angina pectoris: platelet behavior and prognosis in progressive angina and intermediate coronary syndromes. Circulation. 1990;81(suppl I):I-16-I-19.
11.
Theroux P, Latour JG, Leger-Gauthier C, DeLara J. Fibrinopeptide A and platelet factor levels in unstable angina pectoris. Circulation. 1987;75:156-162.
12. Fitzgerald DJ, Roy L, Catella F, Fitzgerald GA. Platelet activation in unstable coronary disease. N Engl J Med. 1986;315:983-989.[Abstract]
13.
Carry M, Korley V, Willerson JT, Weigelt L, Ford-Hutchinson AW, Tagari P. Increased urinary leukotriene excretion in patients with cardiac ischemia. Circulation. 1992;85:230-236.
14.
Kujjpers T, Tool A, Van der Schoot K, Ginset L, Onderwater J, Ross D, Verhoeven A. Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface markers for neutrophil activation. Blood. 1991;78:1105-1111.
15. Macey MG, Jiang XP, Veys P, McCarthy D, Newland AC. Expression of functional antigens on neutrophils: effects of preparation. J Immunol Methods. 1992;149:37-42.[Medline] [Order article via Infotrieve]
16.
Gawaz M, Ott I, Reininger AJ, Heinzmann U, Neumann FJ. Agglutination of isolated platelet membranes. Arterioscler Thromb Vasc Biol. 1996;16:621-627.
17. Gawaz M, Ward R. Effects of hemodialysis on platelet derived thrombospondin. Kidney Int. 1991;40:257-265.[Medline] [Order article via Infotrieve]
18.
Ginsberg M, Frelinger A, Lam S, Forsyt J, McMillan R, Plow E, Shattil S. Analysis of platelet aggregation disorders based on flow cytometric analysis of platelet membrane glycoprotein GPIIb-IIIa with conformation specific monoclonal antibodies. Blood. 1990;76:2017-2023.
19. Gawaz M, Dobos G, Spath M, Mujais S. Platelet membrane glycoprotein GPIIb-IIIa function is impaired in endstage renal failure. J Am Soc Nephrol. 1994;5:36-46.[Abstract]
20.
Neumann F-J, Waas W, Diehm C, Weiss T, Haupt H-M, Zimmermann R, Tillmanns H, Kubler W. Activation and decreased deformability of neutrophils after intermittent claudication. Circulation. 1990;82:922-929.
21.
Neumann F-J, Richardt G, Schneider M, Ott I, Haupt H, Tillmanns H, Schomig A, Rauch B. Cardiac release of chemoattractants after ischaemia induced by coronary balloon angioplasty. Br Heart J. 1993;70:27-34.
22.
Neumann F-J, Ott I, Wilhelm H, Katus H, Tillmanns H, Schomig A. Release of chemoattractants and neutrophil activation in acute myocardial infarction immediately after successful recanalization of the infarct-related vessel by angioplasty. Eur Heart J. 1994;15:171-178.
23. Smyth SS, Parise LV. Regulation of ligand bridging to glycoprotein GPIIb-IIIa (integrin aIIb3) in isolated platelet membranes. Biochem J. 1993;292:749-758.
24. Babior BM, Kipnes RS, Curnutte JT. Biological defense mechanisms: the production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest. 1973;52:741-743.
25. Miller LJ, Bainton DF, Borregaard N, Springer TA. Stimulated mobilization of monocyte Mac-1 and p150,95 adhesion proteins from an intracellular vesicular compartment to the cell surface. J Clin Invest. 1987;80:535-544.
26. Limb GA, Hamblin AS, Wolstencroft RA, Dumonde DC. Selective upregulation of human granulocyte integrins and complement receptor 1 by cytokines. Immunology. 1991;74:696-702.[Medline] [Order article via Infotrieve]
27.
Kishimoto TK, Jutila MA, Berg EL, Butcher EC. Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science. 1989;245:1238-1241.
28. Ginsberg M, Du X. Inside out integrin signalling. Curr Opin Cell Biol. 1992;4:766-771.[Medline] [Order article via Infotrieve]
29. Larsen E, Celi A, Gilbert GE, Furie BC, Erban JK, Bonfanti R, Wagner DD, Furi D. PADGEM protein: a receptor that mediates the interaction of activated platelets and monocytes. Cell. 1989;59:305-311.[Medline] [Order article via Infotrieve]
30.
Hamburger SA, McEver RP. GMP140 mediates adhesion of stimulated platelets to neutrophils. Blood. 1990;75:550-555.
31. Larsen E, Palabrica T, Sajer S, Gilbert GE, Wagner DD, Furie BC, Furie B. PADGEM-dependent adhesion of platelets to monocytes and neutrophils is mediated by lineage specific carbohydrate, LNFII (CD15). Cell. 1990;63:467-484.[Medline] [Order article via Infotrieve]
32. Gawaz M, Loftus JC, Bajt ML, Frojmoviv MM, Plow EF, Ginsberg MH. Ligand bridging mediates integrin (platelet GPIIb-IIIa) dependent homotypic and heterotypic cell-cell interactions. J Clin Invest. 1991;88:1128-1134.
33. Altieri DC, Bader R, Mannucci PM, Edgington TS. Oligospecificity of the cellular adhesion receptor MAC-1 encompasses an inducible recognition specificity for fibrinogen. J Cell Biol. 1988;107:18931-18940.
34. Spangenberg P, Redlich H, Bergmann I, Losche W, Gotzrath M, Kehrel B. The platelet glycoprotein IIb/IIIa complex is involved in the adhesion of activated platelets to leukocytes. Thromb Haemost. 1993;70:514-521.[Medline] [Order article via Infotrieve]
35. Silverstein R, Asch AS, Nachmann RL. Glycoprotein IV mediates thrombospondin-dependent platelet monocyte and platelet-U937 cell adhesion. J Clin Invest. 1989;84:546-552.
36.
Nagata K, Tsuji T, Hanai N, Irimura T. Role of O-linked carbohydrate chains on leukocyte cell membranes in platelet-induced leukocyte activation. J Biol Chem. 1994;269:23290-23295.
37. Nagata K, Tsuji T, Todoroki N, Katagiri Y, Tanoue K, Yamazaki H, Hanai N, Irimura T. Activated platelets induce superoxide anion release by monocytes and neutrophils through P-selectin (CD62). J Immunol. 1993;151:3267-3273.[Abstract]
38.
Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR. Dynamics of leukocyte-platelet adhesion in whole blood. Blood. 1991;78:1730-1737.
39. Hamm C, Lorenz RL, Bleifeld W, Kupper W, Wober W, Weber PC. Biochemical evidence of platelet activations in patients with persistent unstable angina. J Am Coll Cardiol. 1987;10:998-1004.[Abstract]
40.
Sobel M, Salzman EW, Davies GC, Handin RI, Sweeney J, Ploetz J, Kurland G. Circulating platelet products in unstable angina. Circulation. 1981;63:300-306.
41.
Fitzgerald GA, Pedersen AK, Patrono C. Analysis of thromboxane and prostacyclin biosynthesis in cardiovascular disease. Circulation. 1983;67:1174-1175.
42. Dinerman JL, Mehta JL. Endothelial, platelet and leukocyte interactions in ischemic heart disease: insights into potential mechanisms and their clinical relevance. J Am Coll Cardiol. 1990;16:207-222.[Abstract]
This article has been cited by other articles:
 |
|
 |
|
  D. Trenk and F.-J. Neumann Aspirin Resistance: An Underestimated Risk in Patients With Drug-Eluting Stents? J. Am. Coll. Cardiol., August 26, 2008; 52(9): 740 - 742. [Full Text] [PDF]
|
|
|
|
 |
|
 T Geisler, M Kapp, K Gohring-Frischholz, K Daub, C Dosch, B Bigalke, H Langer, C Herdeg, and M Gawaz Residual platelet activity is increased in clopidogrel- and ASA-treated patients with coronary stenting for acute coronary syndromes compared with stable coronary artery disease Heart, June 1, 2008; 94(6): 743 - 747. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wacker, E. Lucchinetti, M. Jamnicki, J. Aguirre, L. Harter, M. Keel, and M. Zaugg Delayed Inhibition of Agonist-Induced Granulocyte-Platelet Aggregation After Low-Dose Sevoflurane Inhalation in Humans Anesth. Analg., June 1, 2008; 106(6): 1749 - 1758. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Brambilla, M. Camera, D. Colnago, G. Marenzi, M. De Metrio, P. L. Giesen, A. Balduini, F. Veglia, K. Gertow, P. Biglioli, et al. Tissue Factor in Patients With Acute Coronary Syndromes: Expression in Platelets, Leukocytes, and Platelet-Leukocyte Aggregates Arterioscler Thromb Vasc Biol, May 1, 2008; 28(5): 947 - 953. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. O'Donoghue, D. A. Morrow, C. P. Cannon, W. Guo, S. A. Murphy, C. M. Gibson, and M. S. Sabatine Association between baseline neutrophil count, clopidogrel therapy, and clinical and angiographic outcomes in patients with ST-elevation myocardial infarction receiving fibrinolytic therapy Eur. Heart J., April 2, 2008; 29(8): 984 - 991. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. May, P. Seizer, and M. Gawaz Platelets: Inflammatory Firebugs of Vascular Walls Arterioscler Thromb Vasc Biol, March 1, 2008; 28(3): s5 - s10. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bournazos, J. Rennie, S. P. Hart, and I. Dransfield Choice of Anticoagulant Critically Affects Measurement of Circulating Platelet-Leukocyte Complexes Arterioscler Thromb Vasc Biol, January 1, 2008; 28(1): e2 - e3. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Inami, S. Nomura, Y. Kimura, K. Yamada, H. Nakamori, N. Takahashi, S. Fukuhara, and T. Iwasaka Evaluation of Platelet and Leukocyte Functions in Effort Angina Patients Using High Shear Conditions in Small-Sized Collagen Bead Columns Clinical and Applied Thrombosis/Hemostasis, October 1, 2007; 13(4): 428 - 431. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Schulz, A. Schafer, M. Stolla, S. Kerstan, M. Lorenz, M.-L. von Bruhl, M. Schiemann, J. Bauersachs, T. Gloe, D. H. Busch, et al. Chemokine Fractalkine Mediates Leukocyte Recruitment to Inflammatory Endothelial Cells in Flowing Whole Blood: A Critical Role for P-Selectin Expressed on Activated Platelets Circulation, August 14, 2007; 116(7): 764 - 773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Itoh, C. Susuki, K. Takeshita, K. Nagata, and T. Tsuji Redistribution of P-selectin glycoprotein ligand-1 (PSGL-1) in chemokine-treated neutrophils: a role of lipid microdomains J. Leukoc. Biol., June 1, 2007; 81(6): 1414 - 1421. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Steinhubl, J. J. Badimon, D. L. Bhatt, J.-M. Herbert, and T. F. Luscher Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease Vascular Medicine, May 1, 2007; 12(2): 113 - 122. [Abstract] [PDF]
|
|
|
|
 |
|
 C. S. Rinder, M. J. Smith, H. M. Rinder, D. N. Cortright, R. M. Brodbeck, J. E. Krause, and B. R. Smith Leukocyte Effects of C5a-Receptor Blockade During Simulated Extracorporeal Circulation Ann. Thorac. Surg., January 1, 2007; 83(1): 146 - 152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Thom, V. M. Bhopale, S.-T. Han, J. M. Clark, and K. R. Hardy Intravascular Neutrophil Activation Due to Carbon Monoxide Poisoning Am. J. Respir. Crit. Care Med., December 1, 2006; 174(11): 1239 - 1248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M R Ray, S Mukherjee, S Roychoudhury, P Bhattacharya, M Banerjee, S Siddique, S Chakraborty, and T Lahiri Platelet activation, upregulation of CD11b/CD18 expression on leukocytes and increase in circulating leukocyte-platelet aggregates in Indian women chronically exposed to biomass smoke Human and Experimental Toxicology, November 1, 2006; 25(11): 627 - 635. [Abstract] [PDF]
|
|
|
|
|
|
K. Yoshida, R. Kondo, Q. Wang, and C. M. Doerschuk Neutrophil Cytoskeletal Rearrangements during Capillary Sequestration in Bacterial Pneumonia in Rats Am. J. Respir. Crit. Care Med., September 15, 2006; 174(6): 689 - 698. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Htun, S. Fateh-Moghadam, B. Tomandl, R. Handschu, K. Klinger, K. Stellos, C. Garlichs, W. Daniel, and M. Gawaz Course of Platelet Activation and Platelet-Leukocyte Interaction in Cerebrovascular Ischemia Stroke, September 1, 2006; 37(9): 2283 - 2287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Mathew, H. M. Rinder, B. R. Smith, M. F. Newman, and C. S. Rinder Transcerebral Platelet Activation After Aortic Cross-Clamp Release is Linked to Neurocognitive Decline. Ann. Thorac. Surg., May 1, 2006; 81(5): 1644 - 1649. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A K Mitra and D K Agrawal In stent restenosis: bane of the stent era. J. Clin. Pathol., March 1, 2006; 59(3): 232 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ferenc and F.-J. Neumann Efficacy of primary PCI: the microvessel perspective Eur. Heart J. Suppl., October 1, 2005; 7(suppl_I): I4 - I9. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.A. Zeller, A. Lenz, C.C. Eschenfelder, P. Zunker, and G. Deuschl Platelet-Leukocyte Interaction and Platelet Activation in Acute Stroke With and Without Preceding Infection Arterioscler Thromb Vasc Biol, July 1, 2005; 25(7): 1519 - 1523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. D. Horne, J. L. Anderson, J. M. John, A. Weaver, T. L. Bair, K. R. Jensen, D. G. Renlund, J. B. Muhlestein, and Intermountain Heart Collaborative (IHC) Study Grou Which White Blood Cell Subtypes Predict Increased Cardiovascular Risk? J. Am. Coll. Cardiol., May 17, 2005; 45(10): 1638 - 1643. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. S. Ritter, K. M. Stempel, B. M. Coull, and P. F. McDonagh Leukocyte-Platelet Aggregates in Rat Peripheral Blood After Ischemic Stroke and Reperfusion Biol Res Nurs, April 1, 2005; 6(4): 281 - 288. [Abstract] [PDF]
|
|
|
|
|
|
N. A. Horn, D. M. Anastase, K. E. Hecker, J. H. Baumert, T. Robitzsch, and R. Rossaint Epinephrine Enhances Platelet-Neutrophil Adhesion in Whole Blood In Vitro Anesth. Analg., February 1, 2005; 100(2): 520 - 526. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Merten, C. Beythien, K. Gutensohn, P. Kuhnl, T. Meinertz, and P. Thiagarajan Sulfatides Activate Platelets Through P-Selectin and Enhance Platelet and Platelet-Leukocyte Aggregation Arterioscler Thromb Vasc Biol, January 1, 2005; 25(1): 258 - 263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Khreiss, L. Jozsef, L. A. Potempa, and J. G. Filep Opposing Effects of C-Reactive Protein Isoforms on Shear-Induced Neutrophil-Platelet Adhesion and Neutrophil Aggregation in Whole Blood Circulation, October 26, 2004; 110(17): 2713 - 2720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G.-S. Huang, C.-Y. Li, P.-C. Hsu, C.-S. Tsai, T.-C. Lin, and C.-S. Wong Sevoflurane Anesthesia Attenuates Adenosine Diphosphate-Induced P-Selectin Expression and Platelet-Leukocyte Conjugate Formation Anesth. Analg., October 1, 2004; 99(4): 1121 - 1126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Frossard, I. Fuchs, J. M. Leitner, K. Hsieh, M. Vlcek, H. Losert, H. Domanovits, W. Schreiber, A. N. Laggner, and B. Jilma Platelet Function Predicts Myocardial Damage in Patients With Acute Myocardial Infarction Circulation, September 14, 2004; 110(11): 1392 - 1397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J A Zeller, K Frahm, R Baron, R Stingele, and G Deuschl Platelet-leukocyte interaction and platelet activation in migraine: a link to ischemic stroke? J. Neurol. Neurosurg. Psychiatry, July 1, 2004; 75(7): 984 - 987. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Xiao and P. Theroux Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome J. Am. Coll. Cardiol., June 2, 2004; 43(11): 1982 - 1988. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Garlichs, S. Eskafi, I. Cicha, A. Schmeisser, B. Walzog, D. Raaz, C. Stumpf, A. Yilmaz, J. Bremer, J. Ludwig, et al. Delay of neutrophil apoptosis in acute coronary syndromes J. Leukoc. Biol., May 1, 2004; 75(5): 828 - 835. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gawaz Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium Cardiovasc Res, February 15, 2004; 61(3): 498 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Cipollone, B. Rocca, and C. Patrono Cyclooxygenase-2 Expression and Inhibition in Atherothrombosis Arterioscler Thromb Vasc Biol, February 1, 2004; 24(2): 246 - 255. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. C. Burger and D. D. Wagner Platelet P-selectin facilitates atherosclerotic lesion development Blood, April 1, 2003; 101(7): 2661 - 2666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.-J. Neumann and N. Jander How to best counteract the enemies? By ensuring adequate oxygen delivery Eur. Heart J. Suppl., November 1, 2002; 4(suppl_G): G35 - G42. [Abstract] [PDF]
|
|
|
|
|
|
F. G.P. Welt and C. Rogers Inflammation and Restenosis in the Stent Era Arterioscler Thromb Vasc Biol, November 1, 2002; 22(11): 1769 - 1776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Santoso, U. J.H. Sachs, H. Kroll, M. Linder, A. Ruf, K. T. Preissner, and T. Chavakis The Junctional Adhesion Molecule 3 (JAM-3) on Human Platelets is a Counterreceptor for the Leukocyte Integrin Mac-1 J. Exp. Med., September 2, 2002; 196(5): 679 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Freedman and J. Loscalzo Platelet-Monocyte Aggregates: Bridging Thrombosis and Inflammation Circulation, May 7, 2002; 105(18): 2130 - 2132. [Full Text] [PDF]
|
|
|
|
|
|
C D Garlichs, S Eskafi, D Raaz, A Schmidt, J Ludwig, M Herrmann, L Klinghammer, W G Daniel, and A Schmeisser Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets Heart, December 1, 2001; 86(6): 649 - 655. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. I. Furman, M. R. Barnard, L. A. Krueger, M. L. Fox, E. A. Shilale, D. M. Lessard, P. Marchese, A. L. Frelinger III, R. J. Goldberg, and A. D. Michelson Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1002 - 1006. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Michelson, M. R. Barnard, L. A. Krueger, C. R. Valeri, and M. I. Furman Circulating Monocyte-Platelet Aggregates Are a More Sensitive Marker of In Vivo Platelet Activation Than Platelet Surface P-Selectin: Studies in Baboons, Human Coronary Intervention, and Human Acute Myocardial Infarction Circulation, September 25, 2001; 104(13): 1533 - 1537. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-F. Theoret, J.-G. Bienvenu, A. Kumar, and Y. Merhi P-Selectin Antagonism with Recombinant P-Selectin Glycoprotein Ligand-1 (rPSGL-Ig) Inhibits Circulating Activated Platelet Binding to Neutrophils Induced by Damaged Arterial Surfaces J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 658 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Mazzone, S De Servi, I Mazzucchelli, I Bossi, E Ottini, M Vezzoli, F Meloni, M Lotzinker, and G Mariani Increased concentrations of inflammatory mediators in unstable angina: correlation with serum troponin T Heart, May 1, 2001; 85(5): 571 - 575. [Abstract] [Full Text]
|
|
|
|
|
|
F.-J. Neumann Optimization of microvascular reperfusion in acute myocardial infarction Eur. Heart J. Suppl., May 1, 2001; 3(suppl_A): A21 - A25. [Abstract] [PDF]
|
|
|
|
|
|
P. Libby and D. I. Simon Inflammation and Thrombosis : The Clot Thickens Circulation, April 3, 2001; 103(13): 1718 - 1720. [Full Text] [PDF]
|
|
|
|
|
|
F.-J. Neumann, W. Hochholzer, G. Pogatsa-Murray, A. Schomig, and M. Gawaz Antiplatelet effects of abciximab, tirofiban and eptifibatide in patients undergoing coronary stenting J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1323 - 1328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-G. Bienvenu, J.-F. Tanguay, J.-F. Theoret, A. Kumar, R. G. Schaub, and Y. Merhi Recombinant Soluble P-Selectin Glycoprotein Ligand-1-Ig Reduces Restenosis Through Inhibition of Platelet-Neutrophil Adhesion After Double Angioplasty in Swine Circulation, February 27, 2001; 103(8): 1128 - 1134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Chamorro Immediate Anticoagulation in Acute Focal Brain Ischemia Revisited : Gathering the Evidence Stroke, February 1, 2001; 32(2): 577 - 578. [Full Text] [PDF]
|
|
|
|
|
|
D. I. Simon, Z. Chen, H. Xu, C. Q. Li, J.-f. Dong, L. V. McIntire, C. M. Ballantyne, L. Zhang, M. I. Furman, M. C. Berndt, et al. Platelet Glycoprotein Ib{alpha} Is a Counterreceptor for the Leukocyte Integrin Mac-1 (Cd11b/Cd18) J. Exp. Med., July 17, 2000; 192(2): 193 - 204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Katayama, Y. Ikeda, M. Handa, T. Tamatani, S. Sakamoto, M. Ito, Y. Ishimura, and M. Suematsu Immunoneutralization of Glycoprotein Ib{alpha} Attenuates Endotoxin-Induced Interactions of Platelets and Leukocytes With Rat Venular Endothelium In Vivo Circ. Res., May 26, 2000; 86(10): 1031 - 1037. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.Y. Jeremy, G.D. Angelini, M. Khan, D.P. Mikhailidis, R.J. Morgan, C.S. Thompson, K.R. Bruckdorfer, and K.M. Naseem Platelets, oxidant stress and erectile dysfunction: an hypothesis Cardiovasc Res, April 1, 2000; 46(1): 50 - 54. [Full Text] [PDF]
|
|
|
|
|
|
F.-J. Neumann, D. Zohlnhofer, L. Fakhoury, I. Ott, M. Gawaz, and A. Schomig Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction J. Am. Coll. Cardiol., November 1, 1999; 34(5): 1420 - 1426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Theilmeier, T. Lenaerts, C. Remacle, D. Collen, J. Vermylen, and M. F. Hoylaerts Circulating Activated Platelets Assist THP-1 Monocytoid/Endothelial Cell Interaction Under Shear Stress Blood, October 15, 1999; 94(8): 2725 - 2734. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Peter, M. Schwarz, C. Conradt, T. Nordt, M. Moser, W. Kubler, and C. Bode Heparin Inhibits Ligand Binding to the Leukocyte Integrin Mac-1 (CD11b/CD18) Circulation, October 5, 1999; 100(14): 1533 - 1539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Y. Jeremy, D. Rowe, A. M. Emsley, and A. C. Newby Nitric oxide and the proliferation of vascular smooth muscle cells Cardiovasc Res, August 15, 1999; 43(3): 580 - 594. [Full Text] [PDF]
|
|
|
|
|
|
C. S. Rinder, H. M. Rinder, K. Johnson, M. Smith, D. L. Lee, J. Tracey, G. Polack, P. Higgins, C. G. Yeh, and B. R. Smith MD Role of C3 Cleavage in Monocyte Activation During Extracorporeal Circulation Circulation, August 3, 1999; 100(5): 553 - 558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Tselepis, J. A. Goudevenos, A. P. Tambaki, L. Michalis, C. S. Stroumbis, D. C. Tsoukatos, M. Elisaf, and D. A. Sideris Platelet aggregatory response to platelet activating factor (PAF), ex vivo, and PAF-acetylhydrolase activity in patients with unstable angina: effect of c7E3 Fab (abciximab) therapy Cardiovasc Res, July 1, 1999; 43(1): 183 - 191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Eguchi, H. Ikeda, T. Murohara, H. Yasukawa, N. Haramaki, S. Sakisaka, and T. Imaizumi Endothelial Injuries of Coronary Arteries Distal to Thrombotic Sites : Role of Adhesive Interaction Between Endothelial P-Selectin and Leukocyte Sialyl LewisX Circ. Res., March 19, 1999; 84(5): 525 - 535. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kumar, M. P. Villani, U. K. Patel, J. C. Keith Jr, and R. G. Schaub Recombinant Soluble Form of PSGL-1 Accelerates Thrombolysis and Prevents Reocclusion in a Porcine Model Circulation, March 16, 1999; 99(10): 1363 - 1369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Merhi, P. Provost, P. Chauvet, J.-F. Theoret, M. L. Phillips, and J.-G. Latour Selectin Blockade Reduces Neutrophil Interaction With Platelets at the Site of Deep Arterial Injury by Angioplasty in Pigs Arterioscler Thromb Vasc Biol, February 1, 1999; 19(2): 372 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gawaz, F.-J. Neumann, and A. Schomig Evaluation of Platelet Membrane Glycoproteins in Coronary Artery Disease : Consequences for Diagnosis and Therapy Circulation, January 12, 1999; 99 (1): e1 - e11. [Full Text] [PDF]
|
|
|
|
|
|
J. K. Mickelson, M. N. Ali, N. S. Kleiman, N. M. Lakkis, T. W. Chow, B. J. Hughes, and C. W. Smith Chimeric 7e3 Fab (ReoPro) decreases detectable CD11b on neutrophils from patients undergoing coronary angioplasty J. Am. Coll. Cardiol., January 1, 1999; 33(1): 97 - 106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Irani, Y. Pham, L. D. Coleman, C. Roos, G. E. Cooke, A. Miodovnik, N. Karim, C. C. Wilhide, P. F. Bray, and P. J. Goldschmidt-Clermont Priming of Platelet {alpha}IIbß3 by Oxidants Is Associated With Tyrosine Phosphorylation of ß3 Arterioscler Thromb Vasc Biol, November 1, 1998; 18(11): 1698 - 1706. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Lefer, B. Campbell, R. Scalia, and D. J. Lefer Synergism Between Platelets and Neutrophils in Provoking Cardiac Dysfunction After Ischemia and Reperfusion : Role of Selectins Circulation, September 29, 1998; 98(13): 1322 - 1328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Ambrosio, I. Tritto, and P. Golino Reactive oxygen metabolites and arterial thrombosis Cardiovasc Res, June 1, 1997; 34(3): 445 - 452. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.-J. Neumann, N. Marx, M. Gawaz, K. Brand, I. Ott, C. Rokitta, C. Sticherling, C. Meinl, A. May, and A. Schomig Induction of Cytokine Expression in Leukocytes by Binding of Thrombin-Stimulated Platelets Circulation, May 20, 1997; 95(10): 2387 - 2394. [Abstract] [Full Text]
|
|
|
|
|
|
M. L. Entman and C. M. Ballantyne Association of Neutrophils With Platelet Aggregates in Unstable Angina: Should We Alter Therapy? Circulation, September 15, 1996; 94(6): 1206 - 1208. [Full Text]
|
|
|
|
|
|
J. Sarma, C. A. Laan, S. Alam, A. Jha, K. A.A. Fox, and I. Dransfield Increased Platelet Binding to Circulating Monocytes in Acute Coronary Syndromes Circulation, May 7, 2002; 105(18): 2166 - 2171. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||